Back
argenx SE 10K Form
Sell
50
ARGNF
argenx SE
Last Price:
$814.94
Seasonality Move:
1.38%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ARGNF News And Ratings
See the #1 stock for the next 7 days that we like better than ARGNF
ARGNF Financial Statistics
Sales & Book Value
| Annual Sales: | $4.2B |
|---|---|
| Cash Flow: | $312.8M |
| Price / Cash Flow: | 119.76 |
| Annual Sales: | $99.66 |
| Price / Book: | 5.5 |
Profitability
| EPS (TTM): | 19.57000 |
|---|---|
| Net Income (TTM): | $1.3B |
| Gross Margin: | $3.7B |
| Return on Equity: | 28.06% |
| Return on Assets: | 21.14% |
argenx SE Earnings Forecast
Key argenx SE Financial Ratios
-
The Gross Profit Margin over the past 15 years for ARGNF is 89.14%.
-
The Selling, General & Administrative Expenses for ARGNF have been equal to 32.93% of Gross Profit Margin.
-
The Research & Development expenses have been 32.86% of Revenue.
-
The Interest Expense is 0.32% of Operating Income.
-
The Net Earning history of ARGNF is 31.12% of Total Revenues.
-
Per Share Earnings over the last 15 years have been positive in 6 years.
argenx SE Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ARGNF |
| Website: | argen-x.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 5.6 |
| Quick Ratio: | 4.92 |
Price-to-Earnings
| Trailing P/E Ratio: | 41.64 |
|---|---|
| Forward P/E Ratio: | 0 |